![]() | ![]() |
Formats:
|
||||||||||||||||||||||
Copyright Wolf et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Identification of Pax6-Dependent Gene Regulatory Networks in the Mouse Lens 1The Departments of Ophthalmology and Visual Sciences and Genetics, Albert Einstein College of Medicine, Bronx, New York, United States of America 2NYU Cancer Institute, New York University Langone Medical Center, New York, New York, United States of America 3Institute of Human Anatomy and Embryology, University of Regensburg, Regensburg, Germany 4Department of Pathology, New York University Langone Medical Center, New York, New York, United States of America Geraldine Butler, Editor University College Dublin, Ireland * E-mail: cvekl/at/aecom.yu.edu Conceived and designed the experiments: AC. Performed the experiments: LVW YY QX BB. Analyzed the data: LVW YY JW ERT JZ AC. Contributed reagents/materials/analysis tools: AC. Wrote the paper: LVW JZ AC. Received June 4, 2008; Accepted November 21, 2008. This article has been corrected. See PLoS ONE. 2009 March 26; 4(3): 10.1371/annotation/71d78295-dc0f-4e78-9c99-45b730952d9b.Abstract Lineage-specific DNA-binding transcription factors regulate development by activating and repressing particular set of genes required for the acquisition of a specific cell type. Pax6 is a paired domain and homeodomain-containing transcription factor essential for development of central nervous, olfactory and visual systems, as well as endocrine pancreas. Haploinsufficiency of Pax6 results in perturbed lens development and homeostasis. Loss-of-function of Pax6 is incompatible with lens lineage formation and results in abnormal telencephalic development. Using DNA microarrays, we have identified 559 genes expressed differentially between 1-day old mouse Pax6 heterozygous and wild type lenses. Of these, 178 (31.8%) were similarly increased and decreased in Pax6 homozygous embryonic telencephalon [Holm PC, Mader MT, Haubst N, Wizenmann A, Sigvardsson M, Götz M (2007) Loss- and gain-of-function analyses reveals targets of Pax6 in the developing mouse telencephalon. Mol Cell Neurosci 34: 99–119]. In contrast, 381 (68.2%) genes were differently regulated between the lens and embryonic telencephalon. Differential expression of nine genes implicated in lens development and homeostasis: Cspg2, Igfbp5, Mab21l2, Nrf2f, Olfm3, Spag5, Spock1, Spon1 and Tgfb2, was confirmed by quantitative RT-PCR, with five of these genes: Cspg2, Mab21l2, Olfm3, Spag5 and Tgfb2, identified as candidate direct Pax6 target genes by quantitative chromatin immunoprecipitation (qChIP). In Mab21l2 and Tgfb2 promoter regions, twelve putative individual Pax6-binding sites were tested by electrophoretic mobility shift assays (EMSAs) with recombinant Pax6 proteins. This led to the identification of two and three sites in the respective Mab21l2 and Tgfb2 promoter regions identified by qChIPs. Collectively, the present studies represent an integrative genome-wide approach to identify downstream networks controlled by Pax6 that control mouse lens and forebrain development. Introduction Embryonic organ development is contingent on complex coordinated interactions of multiple transcription factors that regulate the expression of selected downstream target genes. The Paired (Pax) family of genes has been shown to control development of many organs, such as brain, ear, eye, kidney, muscle, pancreas and thyroid [1], [2]. Nine mammalian Pax genes, Pax1 to Pax9, encode specific DNA-binding transcription factors that recognize DNA via their N-terminal paired domains, PDs. Among them, Pax6 is essential for eye, brain, olfactory and pancreas development [3]–[6]. Gaining insight into the genes regulated directly by Pax6 is fundamental in deciphering its role in the genetic regulatory networks governing embryonic development. During early stages of visual system formation, Pax6 is required for the establishment of lens progenitor cells [7] and for multipotency of retinal progenitor cells [8]. In later stages of eye development, Pax6 plays a number of complex functions during anterior segment [9], lacrimal gland [10] and neuroretina [11] development. The formation of lens progenitor cells appears to require co-expression of at least three genes, Pax6, Six3 and Sox2, in the pre-placodal region of the mouse embryo. Expression of these genes is linked to FGF/MAPK, BMP4 and BMP7 signaling pathways. During the growth and invagination of lens placode, Pax6 controls expression of c-Maf, Foxe3, Mab21l1, N-cadherin, Prox1 [7] and one or more components of retinoic acid (RA) signaling, such as Raldh3/Aldh1a3 [12], [13]. In the differentiating lens fiber cells, Pax6 regulates expression of a number of crystallin genes [7], [14] and the α5β1 integrin complex [15], [16]. In addition to these specific targets, we predict that Pax6 may be engaged in transcriptional regulation of additional cohorts of genes during lens development that can be identified by genome-scale studies. Two recent high throughput studies, focused on the function of Pax6 in mouse telecephalon, have shown a number of novel genes whose expression is controlled by Pax6. A DNA microarray study of Pax6−/− embryonic dorsal (cortex) and ventral (ganglionic eminence, GE) telencephalon, E12 and E15, identified a number of novel Pax6-regulated genes [17]. High-throughput in situ hybridization analysis of hundreds of co-expressed genes in midgestation mouse embryo (E14.5) resulted in the prediction of 30 genes regulated by Pax6 in the embryonic cortex, with ~ one half considered as putative direct target genes [18]. In Drosophila, DNA microarray expression studies identified batteries of genes regulated by eyeless (ey), a fly homologue of Pax6 [19], [20]. In this study, we have analyzed differential gene expression in newborn mouse Pax6 heterozygous and wild type lens and compared this to expression profiles in embryonic forebrain from Pax6 homozygous embryos [17]. We show that approximately 1/3 of differentially expressed transcripts regulated by Pax6 are shared between these model tissues. In contrast, the majority (2/3) of the transcriptional profile represented by the set of 559 transcripts is differently regulated by Pax6 in the respective different cell types. Therefore, our data suggest that specific cellular environments promote common and distinct functions of Pax6. We identified Cspg2, Mab21l2, Olfm3, Spag5, and Tgfb2, as five novel putative direct Pax6-target genes in mouse lens. Finally, we characterized two Pax6-binding sites in the Mab21l2 regulatory region and three Pax6-binding sites in the Tgfb2 promoter. Results Identification of 559 genes differentially expressed in Pax6+/− compared to wild type lens To identify genes regulated by Pax6 in lens, we compared newborn lenses from Pax6+/− to wild type mice (Fig. 1
To assess differential gene expression in newborn mouse Pax6 heterozygous lenses compared to wild type lenses, we performed DNA microarray hybridizations using the Affymetrix Mouse Genome 430 2.0 Arrays. Three biological replicate experiments were performed and analyzed as described in Methods. Initially, we found 591 differentially expressed transcripts in newborn Pax6+/− lenses which represented 559 differentially expressed genes (see Supporting information) from a total number of over 22,000 mouse genes represented on the array. The lens transcriptome was represented by 7,009 (~32%) genes with a median of RMA-normalized raw signal intensities above 100, and 1,844 (~8%) genes with signal intensities between 50–100, respectively. The boxplot shown in Fig. 2A
Downstream pathways sensitive to Pax6 haploinsufficiency The 559 genes were organized according to Gene Ontology (GO) categories of biological process, molecular function and cellular compartment (Fig. 2C
A subcategory “Eye development” within the GO Biological process (Fig. 2C Analysis of differentially expressed genes using the KEGG Pathway classification [27] shows that multiple components of MAPK (e.g. Fgf3, Fgf14 and Fin15), insulin signaling (Aksg, Igfbp5, Isl1, and Nrd1), TGF-β (e.g. Acvr1b, Tgfb1 and Tgfb2) and Wnt (Apc2, Wif1 and Wnt2b) signaling pathways are regulated by Pax6 at the RNA level (Table S1). Regulation of Tgfb2 by Pax6 was further examined as detailed below. Validation of microarray results by quantitative RT-PCR Differential expression of nine genes, Cspg2, Igfbp5, Mab21l2, Nrf2f, Olfm3, Spag5, Spock1, Spon1 and Tgfb2 (Table 1), in Pax6 heterozygous lens was validated using quantitative RT-PCR. This analysis was carried out with cDNAs prepared from independent pools of RNAs, see Methods. The results (see Fig. 3
To further validate the microarray results [33], we performed qRT-PCR analysis of expression of 15 additional genes. Three of these genes, Serpinb6b, Stmn2 and Sultx1, showed more than 2-fold increase/decrease of their expression in Pax6 heterozygous lenses. Seven genes (Ctsh, Aldh1a3, Zw10, Wdhd1, Kif22, Rdm1 and Cdh11) showed 1.24 to 1.45-fold up-regulation. Finally, five genes (Rock1, Dnase2b, Gaa, Acvr1b and Camk1d) showed 1.21 to 1.73-fold down-regulation in this system. Analysis of expression of these genes by qRT-PCR confirmed their deregulation in Pax6 heterozygous lenses (Figs. S2 and S3). In summary, using additional biological replicates, we positively validated differential expression of 25 transcripts of the 559 differentially expressed genes in Pax6+/− lens. Identification of genes commonly regulated by Pax6 in mouse lens and brain Both lens and brain are of the ectodermal germ layer origin. Specific roles of Pax6 were established in the development of both tissues [7], [34]. Taking advantage of expression data from mouse Pax6Sey/Sey embryonic telencephalon [17], we next compared the 559 lens gene list (see above, Supporting information) with differentially expressed genes in E12 and E15 dorsal (cortex, Ctx), and E12 and E15 ventral (the ganglionic eminence, GE) telencephalon [17] as described in Methods. The results identified 178 genes, representing 31.8% of genes identified in Pax6 heterozygous lens, similarly deregulated in various compartments of the mouse telencephalon. Among those genes, kinesin family member 1B (Kif1b), a monomeric motor for anterograde transport of mitochondria [35], was downregulated in each of the five tissues (lens, E12 Ctx, E15 Ctx, E12 GE and E15 GE) examined (Fig. 4
As lens cells and cortical neurons represent distinct cell types, it is not surprising that the majority of 381 (68.2%) Pax6-differentially expressed genes in lens show “opposite” changes in their expression in Pax6 homozygous telencephalon [17]. The “opposite” changes represent contrasting up- and down-regulation of an individual gene or no-change in one tissue combined with either up- or down-regulation in the other system. A list of 31 genes up-/down-regulated in lens and in all four compartments of embryonic telencephalon is shown in Fig. 5
Identification of Pax6's presence in lens chromatin of five genes and identification of Pax6-binding sites in Mab21l2 and Tgfb2 loci The list of differentially expressed genes in lens and telencephalon (see Supporting information) contains both direct and indirect Pax6 target genes. In a separate report (Y.Y., and A.C., unpublished data), we assessed whether Cspg2, Igfbp5, Mab21l2, Nrf2f, Olfm3, Spag5, Sparc1, Spon1 and Tgfb2 genes (Table 1) are Pax6-direct targets by chromatin immunoprecipitation coupled to DNA microarray analysis (ChIP-on-chip) of chromatin obtained from newborn mouse lens. Within this group, the arrays identified presence of Pax6 in five genes, Cspg2, Mab21l2, Olfm3, Spag5, and Tgfb2 (see Figs. S5,S6,S7,S8, and S9, respectively). To confirm Pax6 in these five loci, qChIP assays were performed using primers corresponding to the “peak” regions and surrounding regions in the same locus. The results (see Fig. 6
Direct binding of Pax6 in Mab21l2 and Tgfb2 genes in lens chromatin suggests two novel regulatory mechanisms for embryonic eye development (see Discussion). Therefore, we wanted to localize the putative Pax6-binding sites within the regions occupied by Pax6 in lens chromatin. Using the 20 base pair Pax6 PD “consensus” sequence [36] and a 20 bp Pax6-specific derivative of the 17 base pair PHO (PD/HD) Drosophila paired “consensus” [37] described in Methods and in Fig. S10, we identified five putative Pax6-binding sites corresponding to the “peak” regions identified by ChIP-on-chip in Mab21l2 and seven Pax6-binding sites in Tgfb2 loci, respectively. Based on these 12 predicted binding sites, we prepared 11 probes for EMSAs (see Fig. S10 and Table S4). As candidate sites 11 and 12 in the Tgfb2 Pax6-binding region were close to each other, a single probe was used. The P6CON probe was used to determine the optimal concentration range of GST-Pax6 recombinant proteins, PD and PD/HD, needed to detect specific protein-DNA complexes as we described earlier [15], [38]. Five of eleven probes tested (probe 1, 5, 6, 8 and 11/12, Fig. S10) generated specific protein-DNA complexes that were reduced in the presence of an excess of P6CON cold oligonucleotide competitor, as shown in Fig. 7
Discussion A major question in developmental biology is to elucidate the function of lineage-specific DNA-binding transcription factors encoded by “stage-selector” genes, such as Gata1, HNF4α, MyoD, Mitf, Nr2e3, Nrl, Oct4, Pdx1, PU.1, Pax5/BSAP, Pax6, Runx1, Runx2 and Sox9, in various cell types. Here, we examined the function of Pax6 in mouse lens development by identifying batteries of genes differentially expressed in Pax6 heterozygous lens; Pax6 homozygous embryos (Sey/Sey) do not form any lens [41]. No lens progenitors are formed in the pre-placodal region surrounding the neural plate of the Pax6−/− mouse embryo [42], thus precluding such analysis. As a significant portion of these “stage-selector” genes are expressed in multiple developing lineages, (e.g. Pax6 is expressed in surface ectoderm giving rise to the lens and cornea, in the optic vesicle from which the retina forms, in the neural plate and neuronal progenitor cells, in the olfactory epithelium, in the anterior pituitary primordium and endocrine pancreas [43]), we wanted to determine if there is any overlap between Pax6's functions in the lens and in another tissue, the embryonic telencephalon. Lens- and telencephalon-specific developmental programs regulated by Pax6 Using the Pax6 lens haploinsufficiency experimental model, we identified 559 genes differentially expressed between wild type and Pax6 heterozygous newborn mouse lens. We then took advantage of similar analysis in telencephalon microdissected into the cortex and ganglionic eminence (GE) in Sey/Sey mouse embryos [17] for data comparison. We found that approximately 1/3 of these genes differently expressed in Pax6 haploinsufficient lens were similarly up- or down- co-regulated in four samples dissected from mouse E12 and E15 telencephalon. These 178 genes represent a diverse group in terms of established and/or putative functions of their encoded proteins. Within this group, we found that a locus encoding TGF-β2, which was positively regulated by Pax6 (Fig. 3 Approximately 2/3 of genes studied here were not co-regulated in lens and telencephalon. This analysis suggests that Pax6 actively promotes expression of specific genes in one tissue, i.e. embryonic cortex, while simultaneously repressing their expression in a different cell type, i.e. lens. Thus, it appears that dual functions of Pax6 as a stage-selector gene are to “unfold” a specific developmental program and suppress this specific program in different cellular contexts. For example, transcripts encoding Cspg2, Mab21l2, Olfm3 and Nr2f2 were up-regulated in Pax6 heterozygous lenses (Fig. 3 The examples of neuron-specific genes include NeuroD1, Epha3, Necab2 and Pygb, all upregulated in Pax6 heterozygous lens and downregulated in both compartments of the E12/15 Pax6 homozygous telencephalon (see Fig. 5C Novel insights into genetic networks regulated by Pax6 The ability of an individual regulatory protein to activate and suppress mutually exclusive developmental programs could be a much broader property of the “stage-selector” class of regulatory genes, supported by RNA profiling studies of transcription factors HNF4α in liver, small intestine and fetal colon [57], [58], Crx in embryonic E10.5 retina and adult brain [59], and Runx2 in bone and tooth development [60]–[63]. During hematopoiesis, PU.1 appears to both activate the myeloid differentiation while suppressing the erythroid program [64]. Pax5/BSAP is essential for B-cell development and suppression of alternative cell fates [65]. A recent ChIP-on-chip study of Pax5/BSAP in B-cell development identified binding of this factor during B-cell development [66] consistent with Pax5/BSAP acting as both a transcriptional activator (56%) and a transcriptional repressor (44% of genes), respectively [67]. In retinal progenitor cells, Pax6 also plays dual roles as it is required for both multipotency of these cells and suppression of the premature activation of the photoreceptor-specific differentiation program [68]. Here we show that a complex analysis of differentially expressed genes in lens compared to four related telencephalic samples provide evidence for dual activities of Pax6 both to promote and suppress mutually exclusive developmental programs, during lens and forebrain development. Nevertheless, our data show that there is still a significant fraction of genes that appear to be similarly co-regulated by Pax6 in both systems. Thus, this dual function may be a general property of many other lineage-specific DNA-binding transcription factors. Although we assume that “stage-selector genes” initiate distinct developmental programs through their activities as transcriptional activators and/or repressors, it is not well known which initial targets have to be activated or repressed to achieve formation of committed cell progenitors. Previous studies have suggested that Pax6 directly or indirectly regulates expression of DNA-binding transcription factors Six3, Sox2, Pitx3, Prox1, Sox1, and c-Maf [7], Sox11 [69] as well as transcriptional co-activators Eya1, Eya2 [70] and a co-repressor Dach1 [71] during early stages of lens development, i.e. lens placode and lens vesicle formation. The present study did not identify any novel gene that could be definitively linked to this critical stage of lens development as this would require more direct analysis of gene expression during the formation of lens placode. Interestingly, up-regulation of DNA-binding transcription factor Myb was found in lens and E15 cortex/GE (Fig. 4 In addition, our data identified perturbed expression of a number of genes that participate in a large number of signal transduction pathways (see Fig. 2C Specifically, we found that Mab21l2 is upregulated in Pax6 heterozygous lens (Fig. 3 Within the group of 15 genes used for additional validations, Dnase2b was examined (Fig. S3). DNase IIβ is an enzyme critical for lens terminal differentiation [77], [78]. Reduced expression of Dnase2b transcripts was also observed in an earlier microarray study of the lens-specific knock out of AP-2α gene [79]. Thus, it appears that Dnase2b is genetically downstream of two important regulators of lens development, Pax6 and AP-2α [7]. Our previous efforts to identify genes regulated by Pax6 in lens used much larger quantities of total RNA (~5 µg/sample) obtained from 6-week old lenses [80]. In addition, the experiments were preformed as technical replicates, hybridized using dual-color in house-produced cDNA microarrays, and analyzed using an abandoned fold-change approach. In contrast, in the current study, we used biological replicates, common Affymetrix platform and consensual statistical methods of data analysis [33]. Additional experiments using biological replicates and materials prepared from 6-week lenses would be necessary to achieve a direct comparison of differential gene expression in 1-day and 6-week old Pax6 heterozygous lenses. Integration and comparison of multiple approaches to study Pax6-dependent networks A summary of multiple strategies to identify top candidate genes regulated by Pax6 is shown in Fig. 8
One of the major limitations of genome-wide studies of embryonic development is the limited availability of adequate biological materials. Tissue and organ development depend on formation of multiple cell progenitors of different embryonic origins and their mutual interactions in a complex three-dimensional landscape mediated by short-, mid- and long-range signaling [81]. The major advantage of studying the role of Pax6 during lens development is that the ocular lens is comprised of cells of a single embryonic origin making it relatively easy to isolate pure tissue to obtain RNA and chromatin for genome-scale studies. A development of alternate technologies to process and analyze the ChIP studies, such as ChIP-seq [82] will allow identification of those genomic regions such as distal 5′- and 3′-enhnacers occupied by Pax6 that are not included in the ChIP-on-chip promoter arrays. Future studies will be aimed to probe the molecular mechanism of Pax6 using a selected group of putative target genes identified in this study. Materials and Methods Immunohistochemistry Eyes were obtained from Pax6lacZ/+ mice [6] and normal littermates at postnatal day (P) 1. The genotypes were determined by PCR analysis on DNA extracted from the tail. For PCR analysis the following primers were used: sense 5′-CCGGCCGCTTGGGTGGAG- 3′, antisense 5′-CGG TCCGCCACACCCAGC- 3′. After enucleation, the eyes were fixed for 24 h in 4% paraformaldehyde, washed extensively in phosphate buffered saline (PBS), incubated in ascending (10%, 20%, 30%) concentrations of sucrose/PBS for 8 h to overnight at 4°C and shock frozen in tissue freezing medium (DiaTec, Hallstadt, Germany). Sections of 10–12 µm were cut at −30°C, washed three times in PBS (5 min each), and blocked with 2% BSA in PBS (45 min at room temperature). The primary Pax6 antibody (Eurogentec, Seraing, Belgium) was diluted (1 50) in blocking solution and incubated at 4°C overnight. After three washes in PBS (5 min each), the secondary antibody, diluted in blocking solution, was applied for 1 h (Alexa 488, goat anti rabbit, 1 1000, Invitrogen, Karlsruhe, Germany). After three washes with PBS, counterstaining was performed with DAPI and the sections were embedded with fluorescent mounting medium (Dako, Hamburg, Germany).DNA microarray hybridizations Total RNA was isolated from individual wild type (NMRI background) and Pax6 heterozygous (Pax6lacZ/+) 1-day old lenses (2 lenses from the same mouse per sample) using the RNeasy MiniElute Kit (Qiagen, Valencia, CA) according to manufacturer's instructions. RNA quality was determined with an Agilent 2100 Bioanalyzer and cDNAs were then generated with the Ovation™ Biotin RNA amplification and Labeling System (Nugen, San Carlos, CA) using 50 ng of RNA according to the manufacturer's protocol. Three biological replicates were subsequently hybridized on Mouse Genome 430 2.0 Arrays (Affymetrix, Santa Clara, CA). Animal husbandry and experiments were conducted in accordance with the approved protocol of the Albert Einstein College of Medicine Animal Institute Committee and the ARVO Statement for the use of animals in Ophthalmic and Vision Research. Bioinformatic tools and statistical filtering of RNA microarray results Genes/mRNAs differentially regulated between wild-type and heterozygous (Pax6+/−) P1 lens were identified using triplicate sets of Robust multichip average (RMA)-normalized Affymetrix CEL files [83] by Student's T-test (p<0.10) and by Pavlidis Template Matching (PTM, p<0.05) [84]. Primary data from this study were deposited in the NCBI Gene Expression Omnibus database under accession number GSE13244. The R-based extension to GeneSpring 7.2 (Agilent Technologies, Santa Clara, CA) was used to create a boxplot representation of 559 Pax6 target genes in Fig. 1A Quantitative RT-PCR (qRT-PCR) Relative expression levels of ten genes encoding Cspg2, Igfbp5, Mab21l2, Nr2f2, Olfm3, Pax6, Spag5, Spock1, Spon1 and Tgfb2 in WT and Pax6+/− lenses were determined using qRT-PCR (see Table S3 for oligonucleotides). For data normalization, expression of three reference genes, B2M, HPRT and SDMA was examined. Total RNA was isolated using Trizol® Reagent (Invitrogen, Carlsbad, CA), according to the manufacturer's instruction and digested with DNase I (Promega, Madison, WI). cDNA was subsequently generated with oligo(dT20) primers (Invitrogen) and Superscript ™ III Reverse Transcriptase (Invitrogen), according to the manufacturer's protocol. The cDNA was diluted 10 times and qRT-PCR was conducted using an Applied Biosystems (ABI, Foster City, CA) 7900HT fast Real-Time PCR system with Power SYBR® Green PCR master mix (ABI). qRT-PCR was conducted with the primers shown in Table S2. The primers were designed using Primer3 and cross-checked by NCBI BLAST. Transcripts encoding B2M, SDHA, and HPRT [86] genes were used for normalization of expression levels in Pax6 heterozygous lenses. As no significant changes of expression of B2M, SDHA and HPRT were found, the final data were expressed relative to the expression level of B2M. RNAs prepared from three biological replicates were analyzed as shown in Figs. 2 Chromatin Immunoprecipitations (ChIPs) For the ChIP-on-chip studies, the “standard” assays using chromatin prepared from 20 lenses [22] were scaled up 5-times to proceed with the chromatin obtained from 100 lenses (CD-1 mouse, Charles River Laboratories, Wilmington, MA). Three biological replicates were performed and analyzed. The complete analysis will be published elsewhere. For quantitative ChIPs, 40 microdissected P1 lenses were crosslinked in freshly prepared 1% formaldehyde for 15 minutes at room temperature. The crosslinking was stopped by 0.125 M glycine. The lenses were lysed and homogenized on ice followed by sonication using Bioruptor (Diagenode, Sparta, NJ) to 200–500 bp fragments. Chromatin was further cleared using Protein A and G beads (Sigma, St. Louis, MO) and immunoprecipitated with 5 µg anti-Pax6 antibody (H-295X, Santa Cruz Biotechnology, Santa Cruz, CA) in a total volume of 1 ml. After three washes, crosslinking was reversed and enriched chromatin was eluted into 250 µl H2O using the QIAquick Spin Gel Purification Kit (Qiagen). The PCR primers were designed using Primer3 and their specificity was checked using BLAST. Default parameters were used (GC% no more than 60%, 18–22 bp length and Tm = 60°C), and PCR products were limited to 80–100 bp. The primers are given in Table S2. Quantitative PCR was conducted using a 3-step protocol consisting of 40 cycles of denaturation at 95°C for 30 seconds, annealing at 60°C for 30 seconds and extension at 72°C for 30 seconds with ABI 7900HT equipment in a total volume of 8 µl.Raw data were calculated and analyzed using SDS2.1 software (ABI). Ct values of series dilution of input samples (0.05%, 0.2% and 1% input) were used to generate standard curves. Immunoprecipitation data were referred to the standard curve and normalized to relative input units. Every sample was tested in triplicate per individual 384-well microplate and repeated as three independent biological experiments. Prediction of Pax6-binding sites and EMSAs The putative Pax6-binding sites in four genomic regions of Mab21l2 and Tgfb2 loci were identified using two Pax6 consensus binding site sequences. First, P6CON (ANNTTCACGCWTSANTKMNY, [36]) sequences were identified within regions identified by ChIP-on-chip signals using FUZZNUC algorithm (http://mobyle.pasteur.fr/cgi-bin/MobylePortal/portal.py?formfuzznuc). Second, to identify those Pax6-binding sites that contain the homeodomain binding sequence (underlined), the PHO Drosophila paired protein consensus sequence 5′-CAATTAGTCACGCTTGA-3′ [37] was used to identify 12 natural Pax6 HD-containing binding sites described in the literature (AC, unpublished data) to obtain Pax6-specific alignment that generated an improved 20 bp “consensus” sequence 5′-MNATTATTNNNNCWTGANNG-3′, P6PHD (see Fig. S10). (The common “core” sequence between P6CON and P6PHD is shown in bold). Both PHO and P6PHD sequences were tested as described above for P6CON. Eleven double stranded oligonucleotide probes (Table S4) were labeled and tested in EMSAs. As sites 11 and 12 were next to each other, a single oligonucleotide, site 11/12, was examined. Briefly, recombinant Pax6 GST-PD and GST-PD/HD proteins were expressed in E.coli (BL21 DE3), incubated with 0.5–1 ng of the 5′-end labeled oligonucleotide in the presence of 2 µg of poly[d(I−C)] (Pharmacia, Piscataway, NJ) at room temperature for 10 mins. The optimal amounts of proteins were determined using the P6CON probe as we described elsewhere [15]. Individual oligonucleotide probes were incubated with identical amounts of Pax6 GST-PD and GST-PD/HD proteins and specific protein-DNA complexes were resolved by 5% PAGE in 0.5xTBE buffer. In some reactions, 50 ng of cold oligonucleotides were used as specific competitors. Figure S1 Immunofluorescence detection of Pax6 in lens epithelium. Panels (A–C) are newborn Pax6 WT lenses, panels (D–F) are Pax6 heterozygous lenses. White arrows in (F) demonstrate cells expressing higher levels of Pax6 in the epithelium than those cells marked by the red arrows. Abbreviations: epithelium; e, fiber cells; f. Scale bar = 20 µm.(5.47 MB TIF) Click here for additional data file.(5.2M, tif) Figure S2 Verification of microarray results of up-regulated transcripts in Pax6+/− lens by qRT-PCR. Relative expression levels of Serpinb6b, Rdm1, Ctsh, Zw10, Stmn2, Cdh11, Aldh1a3, Kif22 and Wdhd1 transcripts in wild type (WT, shown in black) and Pax6+/− (het, shown in grey) lenses were determined using qRT-PCR as described in Methods and in legend to Fig. 3 (0.62 MB TIF) Click here for additional data file.(603K, tif) Figure S3 Verification of microarray results of down-regulated transcripts by qRT-PCR. Relative expression levels of Acvr1b, Dnase2b, Sultx1, Rock1, Camk1d and Gaa transcripts in wild type (WT, shown in black) and Pax6+/− (het, shown in grey) lenses were determined using qRT-PCR as described in Methods and in legend to Fig. 3 (0.96 MB TIF) Click here for additional data file.(939K, tif) Figure S4 Genes regulated by Pax6 in lens and one region of embryonic telencephalon. A representative list of 43 genes regulated by Pax6 in lens. 19 of these genes shown here (from the total number of 127) were also differentially expressed in a single region of the developing telencephalon. These genes were grouped into six categories: Chromatin regulation, Mitosis, and Signaling (FGF, RA, TGFβ/BMP, and Wnt). (2.02 MB TIF) Click here for additional data file.(1.9M, tif) Figure S5 Identification of Pax6-binding in regulatory regions of Cspg2/Vcan in lens chromatin by ChIP-on-chip. The upper part shows chromosomal localization, direction of transcription and evolutionar conservation of the genomic regions from eight species as displayed by the UC Santa Cruz Genome Browser. Integrate ChIP signal (input) is shown from three (one) biological replicates, respectively. (6.94 MB TIF) Click here for additional data file.(6.6M, tif) Figure S6 Identification of Pax6-binding in regulatory regions of Mab21l2 in lens chromatin by ChIP-on-chip. The upper part shows chromosomal localization, direction of transcription and evolutionar conservation of the genomic regions from eight species as displayed by the UC Santa Cruz Genome Browser. Integrate ChIP signal (input) is shown from three (one) biological replicates, respectively. (7.54 MB DOC) Click here for additional data file.(7.1M, doc) Figure S7 Identification of Pax6-binding in regulatory regions of Olfm3 in lens chromatin by ChIP-on-chip. The upper part shows chromosomal localization, direction of transcription and evolutionar conservation of the genomic regions from eight species as displayed by the UC Santa Cruz Genome Browser. Integrate ChIP signal (input) is shown from three (one) biological replicates, respectively. (6.48 MB TIF) Click here for additional data file.(6.1M, tif) Figure S8 Identification of Pax6-binding in regulatory regions of Spag5 in lens chromatin by ChIP-on-chip. The upper part shows chromosomal localization, direction of transcription and evolutionar conservation of the genomic regions from eight species as displayed by the UC Santa Cruz Genome Browser. Integrate ChIP signal (input) is shown from three (one) biological replicates, respectively. (6.24 MB TIF) Click here for additional data file.(5.9M, tif) Figure S9 Identification of Pax6-binding in regulatory regions of Tgfb2 in lens chromatin by ChIP-on-chip. The upper part shows chromosomal localization, direction of transcription and evolutionar conservation of the genomic regions from eight species as displayed by the UC Santa Cruz Genome Browser. Integrate ChIP signal (input) is shown from three (one) biological replicates, respectively. (6.20 MB TIF) Click here for additional data file.(5.9M, tif) Figure S10 A list of putative Pax6-binding sites in Mab21l2 and Tgfb2 loci. A) P6CON, PHO and P6PHD “consensus” sequences. B) Alignment with twelve predicted Pax6-binding sites (site 1 to 12). These sites are grouped as “active” and “inactive” sites. Conserved nucleotide (upper case letters), non-conserved nucleotides (lower case letters). Total number of missmatches (n) between the examined site and the “consensus” sequence and orientation (ori) of the respective site in the promoter (forward, +; reverse, −) is also given. (0.69 MB TIF) Click here for additional data file.(671K, tif) Table S1 A “559” master gene list of differentially expressed transcripts in Pax6 heterozygous lens. The transcripts are organized alphabetically into two group, upregulated (yellow) and downregulated (blue), respectively. Average fold change (FC) in Pax6+/− lens is shown. Although a number of transcripts show relatively small fold changes, they were included as they both passed the statistical criteria, and, may represent genes whose expression is severely deregulated in a hypothetical Pax6−/− lens. (0.10 MB XLS) Click here for additional data file.(94K, xls) Table S3 Primers used for Pax6 analysis in lens chromatin by qChIP. (0.04 MB DOC) Click here for additional data file.(39K, doc) Table S4 A list of putative Pax6-binding sites in Mab21l2 and Tgfb2 loci. A) P6CON, PHO and P6PHD “consensus” sequences. B) Alignment with twelve predicted Pax6-binding sites (site 1 to 12). These sites are grouped as “active” and “inactive” sites. Conserved nucleotide (upper case letters), non-conserved nucleotides (lower case letters). Total number of missmatches (n) between the examined site and the “consensus” sequence and orientation (ori) of the respective site in the promoter (forward, +; reverse, −) is also given. (0.03 MB DOC) Click here for additional data file.(31K, doc) Acknowledgments We thank Dr. Wei Li for advice on MAT use, and Drs. Pontus C. Holm and Jovica Ninkovic for expression data of mouse telencephalon. We thank Dr. Barbara K. Birshtein for critical reading of the manuscript. We thank Drs. Jonathan Epstein and Richard Maas for providing the Pax6 GST expression clones, and Dr. Peter Gruss for providing the Pax6lacZ/+ mice. We thank AECOM Genomic Core Facility and NYU Cancer Institute Genomics Facility for expert assistance with microarray hybridizations. We thank Tatyana Harris for help to prepare illustrations. Footnotes References 1. Chi N, Epstein JA. Getting your Pax straight: Pax proteins in development and disease. Trends Genet. 2002;18:41–47. [PubMed] 2. Buckingham M, Relaix F. The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions. Annu Rev Cell Dev Biol. 2007;23:645–673. [PubMed] 3. Hill RE, Favor J, Hogan BL, Ton CC, Saunders GF, et al. Mouse small eye results from mutations in a paired-like homeobox-containing gene. Nature. 1991;354:522–525. [PubMed] 4. Schmahl W, Knoedlseder M, Favor J, Davidson D. Defects of neuronal migration and the pathogenesis of cortical malformations are associated with Small eye (Sey) in the mouse, a point mutation at the Pax-6-locus. Acta Neuropathol (Berl). 1993;86:126–135. [PubMed] 5. Stoykova A, Fritsch R, Walther C, Gruss P. Forebrain patterning defects in Small eye mutant mice. Development. 1996;122:3453–3465. [PubMed] 6. St-Onge L, Sosa-Pineda B, Chowdhury K, Mansouri A, Gruss P. Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas. Nature. 1997;387:406–409. [PubMed] 7. Cvekl A, Duncan MK. Genetic and epigenetic mechanisms of gene regulation during lens development. Prog Retin Eye Res. 2007;26:555–597. [PubMed] 8. Marquardt T, Ashery-Padan R, Andrejewski N, Scardigli R, Guillemot F, et al. Pax6 is required for the multipotent state of retinal progenitor cells. Cell. 2001;105:43–55. [PubMed] 9. Cvekl A, Tamm ER. Anterior eye development and ocular mesenchyme: new insights from mouse models and human diseases. Bioessays. 2004;26:374–386. [PubMed] 10. Makarenkova HP, Ito M, Govindarajan V, Faber SC, Sun L, et al. FGF10 is an inducer and Pax6 a competence factor for lacrimal gland development. Development. 2000;127:2563–2572. [PubMed] 11. Marquardt T, Gruss P. Generating neuronal diversity in the retina: one for nearly all. Trends Neurosci. 2002;25:32–38. [PubMed] 12. Suzuki R, Shintani T, Sakuta H, Kato A, Ohkawara T, et al. Identification of RALDH-3, a novel retinaldehyde dehydrogenase, expressed in the ventral region of the retina. Mech Dev. 2000;98:37–50. [PubMed] 13. Enwright JF, 3rd, Grainger RM. Altered retinoid signaling in the heads of small eye mouse embryos. Dev Biol. 2000;221:10–22. [PubMed] 14. Cvekl A, Piatigorsky J. Lens development and crystallin gene expression: many roles for Pax-6. Bioessays. 1996;18:621–630. [PubMed] 15. Duncan MK, Kozmik Z, Cveklova K, Piatigorsky J, Cvekl A. Overexpression of PAX6(5a) in lens fiber cells results in cataract and upregulation of (alpha)5(beta)1 integrin expression. J Cell Sci. 2000;113 (Pt 18):3173–3185. [PubMed] 16. Donner AL, Ko F, Episkopou V, Maas RL. Pax6 is misexpressed in Sox1 null lens fiber cells. Gene Expr Patterns. 2007;7:606–613. [PubMed] 17. Holm PC, Mader MT, Haubst N, Wizenmann A, Sigvardsson M, et al. Loss- and gain-of-function analyses reveal targets of Pax6 in the developing mouse telencephalon. Mol Cell Neurosci. 2007;34:99–119. [PubMed] 18. Visel A, Carson J, Oldekamp J, Warnecke M, Jakubcakova V, et al. Regulatory pathway analysis by high-throughput in situ hybridization. PLoS Genet. 2007;3:1867–1883. [PubMed] 19. Michaut L, Flister S, Neeb M, White KP, Certa U, et al. Analysis of the eye developmental pathway in Drosophila using DNA microarrays. Proc Natl Acad Sci U S A. 2003;100:4024–4029. [PubMed] 20. Ostrin EJ, Li Y, Hoffman K, Liu J, Wang K, et al. Genome-wide identification of direct targets of the Drosophila retinal determination protein Eyeless. Genome Res. 2006;16:466–476. [PubMed] 21. Collinson JM, Quinn JC, Buchanan MA, Kaufman MH, Wedden SE, et al. Primary defects in the lens underlie complex anterior segment abnormalities of the Pax6 heterozygous eye. Proc Natl Acad Sci U S A. 2001;98:9688–9693. [PubMed] 22. Yang Y, Stopka T, Golestaneh N, Wang Y, Wu K, et al. Regulation of alphaA-crystallin via Pax6, c-Maf, CREB and a broad domain of lens-specific chromatin. Embo J. 2006;25:2107–2118. [PubMed] 23. Baulmann DC, Ohlmann A, Flugel-Koch C, Goswami S, Cvekl A, et al. Pax6 heterozygous eyes show defects in chamber angle differentiation that are associated with a wide spectrum of other anterior eye segment abnormalities. Mech Dev. 2002;118:3–17. [PubMed] 24. Duncan MK, Haynes JI, 2nd, Cvekl A, Piatigorsky J. Dual roles for Pax-6: a transcriptional repressor of lens fiber cell-specific beta-crystallin genes. Mol Cell Biol. 1998;18:5579–5586. [PubMed] 25. Kralova J, Czerny T, Spanielova H, Ratajova V, Kozmik Z. Complex regulatory element within the gammaE- and gammaF-crystallin enhancers mediates Pax6 regulation and is required for induction by retinoic acid. Gene. 2002;286:271–282. [PubMed] 26. Yang Y, Chauhan BK, Cveklova K, Cvekl A. Transcriptional regulation of mouse alphaB- and gammaF-crystallin genes in lens: opposite promoter-specific interactions between Pax6 and large Maf transcription factors. J Mol Biol. 2004;344:351–368. [PubMed] 27. Al-Shahrour F, Minguez P, Tarraga J, Medina I, Alloza E, et al. FatiGO +: a functional profiling tool for genomic data. Integration of functional annotation, regulatory motifs and interaction data with microarray experiments. Nucleic Acids Res. 2007;35:W91–96. [PubMed] 28. Yamada R, Mizutani-Koseki Y, Koseki H, Takahashi N. Requirement for Mab21l2 during development of murine retina and ventral body wall. Dev Biol. 2004;274:295–307. [PubMed] 29. Chow KL, Hall DH, Emmons SW. The mab-21 gene of Caenorhabditis elegans encodes a novel protein required for choice of alternate cell fates. Development. 1995;121:3615–3626. [PubMed] 30. Tripodi M, Filosa A, Armentano M, Studer M. The COUP-TF nuclear receptors regulate cell migration in the mammalian basal forebrain. Development. 2004;131:6119–6129. [PubMed] 31. Gruber J, Harborth J, Schnabel J, Weber K, Hatzfeld M. The mitotic-spindle-associated protein astrin is essential for progression through mitosis. J Cell Sci. 2002;115:4053–4059. [PubMed] 32. Zaccarini R, Cordelieres FP, Martin P, Saule S. Pax6p46 binds chromosomes in the pericentromeric region and induces a mitosis defect when overexpressed. Invest Ophthalmol Vis Sci. 2007;48:5408–5419. [PubMed] 33. Allison DB, Cui X, Page GP, Sabripour M. Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet. 2006;7:55–65. [PubMed] 34. Simpson TI, Price DJ. Pax6; a pleiotropic player in development. Bioessays. 2002;24:1041–1051. [PubMed] 35. Nangaku M, Sato-Yoshitake R, Okada Y, Noda Y, Takemura R, et al. KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. Cell. 1994;79:1209–1220. [PubMed] 36. Epstein J, Cai J, Glaser T, Jepeal L, Maas R. Identification of a Pax paired domain recognition sequence and evidence for DNA-dependent conformational changes. J Biol Chem. 1994;269:8355–8361. [PubMed] 37. Jun S, Desplan C. Cooperative interactions between paired domain and homeodomain. Development. 1996;122:2639–2650. [PubMed] 38. Yang Y, Cvekl A. Tissue-specific regulation of the mouse alphaA-crystallin gene in lens via recruitment of Pax6 and c-Maf to its promoter. J Mol Biol. 2005;351:453–469. [PubMed] 39. Underhill DA, Gros P. The paired-domain regulates DNA binding by the homeodomain within the intact Pax-3 protein. J Biol Chem. 1997;272:14175–14182. [PubMed] 40. Suter DM, Tirefort D, Julien S, Krause KH. A Sox1 to Pax6 switch drives neuroectoderm to radial glia progression during differentiation of mouse embryonic stem cells. Stem Cells. 2008 41. Hogan BL, Horsburgh G, Cohen J, Hetherington CM, Fisher G, et al. Small eyes (Sey): a homozygous lethal mutation on chromosome 2 which affects the differentiation of both lens and nasal placodes in the mouse. J Embryol Exp Morphol. 1986;97:95–110. [PubMed] 42. Grindley JC, Davidson DR, Hill RE. The role of Pax-6 in eye and nasal development. Development. 1995;121:1433–1442. [PubMed] 43. Walther C, Gruss P. Pax-6, a murine paired box gene, is expressed in the developing CNS. Development. 1991;113:1435–1449. [PubMed] 44. Dunker N, Krieglstein K. Reduced programmed cell death in the retina and defects in lens and cornea of Tgfbeta2(−/−) Tgfbeta3(−/−) double-deficient mice. Cell Tissue Res. 2003;313:1–10. [PubMed] 45. Saika S, Saika S, Liu CY, Azhar M, Sanford LP, et al. TGFbeta2 in corneal morphogenesis during mouse embryonic development. Dev Biol. 2001;240:419–432. [PubMed] 46. Ittner LM, Wurdak H, Schwerdtfeger K, Kunz T, Ille F, et al. Compound developmental eye disorders following inactivation of TGFbeta signaling in neural-crest stem cells. J Biol. 2005;4:11. [PubMed] 47. Grocott T, Frost V, Maillard M, Johansen T, Wheeler GN, et al. The MH1 domain of Smad3 interacts with Pax6 and represses autoregulation of the Pax6 P1 promoter. Nucleic Acids Res. 2007;35:890–901. [PubMed] 48. Gotz M, Stoykova A, Gruss P. Pax6 controls radial glia differentiation in the cerebral cortex. Neuron. 1998;21:1031–1044. [PubMed] 49. Heins N, Malatesta P, Cecconi F, Nakafuku M, Tucker KL, et al. Glial cells generate neurons: the role of the transcription factor Pax6. Nat Neurosci. 2002;5:308–315. [PubMed] 50. Sakurai K, Osumi N. The neurogenesis-controlling factor, Pax6, inhibits proliferation and promotes maturation in murine astrocytes. J Neurosci. 2008;28:4604–4612. [PubMed] 51. Miyata T, Maeda T, Lee JE. NeuroD is required for differentiation of the granule cells in the cerebellum and hippocampus. Genes Dev. 1999;13:1647–1652. [PubMed] 52. Kudo C, Ajioka I, Hirata Y, Nakajima K. Expression profiles of EphA3 at both the RNA and protein level in the developing mammalian forebrain. J Comp Neurol. 2005;487:255–269. [PubMed] 53. Canela L, Lujan R, Lluis C, Burgueno J, Mallol J, et al. The neuronal Ca(2+) -binding protein 2 (NECAB2) interacts with the adenosine A(2A) receptor and modulates the cell surface expression and function of the receptor. Mol Cell Neurosci. 2007;36:1–12. [PubMed] 54. Bernier G, Vukovich W, Neidhardt L, Herrmann BG, Gruss P. Isolation and characterization of a downstream target of Pax6 in the mammalian retinal primordium. Development. 2001;128:3987–3994. [PubMed] 55. Ballif BA, Carey GR, Sunyaev SR, Gygi SP. Large-scale identification and evolution indexing of tyrosine phosphorylation sites from murine brain. J Proteome Res. 2008;7:311–318. [PubMed] 56. Chandra S, Fornai F, Kwon HB, Yazdani U, Atasoy D, et al. Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Proc Natl Acad Sci U S A. 2004;101:14966–14971. [PubMed] 57. Battle MA, Konopka G, Parviz F, Gaggl AL, Yang C, et al. Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc Natl Acad Sci U S A. 2006;103:8419–8424. [PubMed] 58. Garrison WD, Battle MA, Yang C, Kaestner KH, Sladek FM, et al. Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon. Gastroenterology. 2006;130:1207–1220. [PubMed] 59. Livesey FJ, Furukawa T, Steffen MA, Church GM, Cepko CL. Microarray analysis of the transcriptional network controlled by the photoreceptor homeobox gene Crx. Curr Biol. 2000;10:301–310. [PubMed] 60. James MJ, Jarvinen E, Wang XP, Thesleff I. Different roles of Runx2 during early neural crest-derived bone and tooth development. J Bone Miner Res. 2006;21:1034–1044. [PubMed] 61. Stock M, Schafer H, Fliegauf M, Otto F. Identification of novel genes of the bone-specific transcription factor Runx2. J Bone Miner Res. 2004;19:959–972. [PubMed] 62. Hecht J, Seitz V, Urban M, Wagner F, Robinson PN, et al. Detection of novel skeletogenesis target genes by comprehensive analysis of a Runx2(−/−) mouse model. Gene Expr Patterns. 2007;7:102–112. [PubMed] 63. Vaes BL, Ducy P, Sijbers AM, Hendriks JM, van Someren EP, et al. Microarray analysis on Runx2-deficient mouse embryos reveals novel Runx2 functions and target genes during intramembranous and endochondral bone formation. Bone. 2006;39:724–738. [PubMed] 64. Stopka T, Amanatullah DF, Papetti M, Skoultchi AI. PU.1 inhibits the erythroid program by binding to GATA-1 on DNA and creating a repressive chromatin structure. Embo J. 2005;24:3712–3723. [PubMed] 65. Cobaleda C, Schebesta A, Delogu A, Busslinger M. Pax5: the guardian of B cell identity and function. Nat Immunol. 2007;8:463–470. [PubMed] 66. Schebesta A, McManus S, Salvagiotto G, Delogu A, Busslinger GA, et al. Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function. Immunity. 2007;27:49–63. [PubMed] 67. Delogu A, Schebesta A, Sun Q, Aschenbrenner K, Perlot T, et al. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity. 2006;24:269–281. [PubMed] 68. Oron-Karni V, Farhy C, Elgart M, Marquardt T, Remizova L, et al. Dual requirement for Pax6 in retinal progenitor cells. Development. 2008;135:4037–4047. [PubMed] 69. Wurm A, Sock E, Fuchshofer R, Wegner M, Tamm ER. Anterior segment dysgenesis in the eyes of mice deficient for the high-mobility-group transcription factor Sox11. Exp Eye Res. 2008;86:895–907. [PubMed] 70. Xu PX, Woo I, Her H, Beier DR, Maas RL. Mouse Eya homologues of the Drosophila eyes absent gene require Pax6 for expression in lens and nasal placode. Development. 1997;124:219–231. [PubMed] 71. Purcell P, Oliver G, Mardon G, Donner AL, Maas RL. Pax6-dependence of Six3, Eya1 and Dach1 expression during lens and nasal placode induction. Gene Expr Patterns. 2005;6:110–118. [PubMed] 72. Plaza S, Turque N, Dozier C, Bailly M, Saule S. C-Myb acts as transcriptional activator of the quail PAX6 (PAX-QNR) promoter through two different mechanisms. Oncogene. 1995;10:329–340. [PubMed] 73. Wawersik S, Purcell P, Rauchman M, Dudley AT, Robertson EJ, et al. BMP7 acts in murine lens placode development. Dev Biol. 1999;207:176–188. [PubMed] 74. Gotoh N, Ito M, Yamamoto S, Yoshino I, Song N, et al. Tyrosine phosphorylation sites on FRS2alpha responsible for Shp2 recruitment are critical for induction of lens and retina. Proc Natl Acad Sci U S A. 2004;101:17144–17149. [PubMed] 75. Yamada R, Mizutani-Koseki Y, Hasegawa T, Osumi N, Koseki H, et al. Cell-autonomous involvement of Mab21l1 is essential for lens placode development. Development. 2003;130:1759–1770. [PubMed] 76. Baldessari D, Badaloni A, Longhi R, Zappavigna V, Consalez GG. MAB21L2, a vertebrate member of the Male-abnormal 21 family, modulates BMP signaling and interacts with SMAD1. BMC Cell Biol. 2004;5:48. [PubMed] 77. Nishimoto S, Kawane K, Watanabe-Fukunaga R, Fukuyama H, Ohsawa Y, et al. Nuclear cataract caused by a lack of DNA degradation in the mouse eye lens. Nature. 2003;424:1071–1074. [PubMed] 78. De Maria A, Bassnett S. DNase IIbeta distribution and activity in the mouse lens. Invest Ophthalmol Vis Sci. 2007;48:5638–5646. [PubMed] 79. Pontoriero GF, Deschamps P, Ashery-Padan R, Wong R, Yang Y, et al. Cell autonomous roles for AP-2alpha in lens vesicle separation and maintenance of the lens epithelial cell phenotype. Dev Dyn. 2008;237:602–617. [PubMed] 80. Chauhan BK, Reed NA, Zhang W, Duncan MK, Kilimann MW, et al. Identification of genes downstream of Pax6 in the mouse lens using cDNA microarrays. J Biol Chem. 2002;277:11539–11548. [PubMed] 81. Barolo S, Posakony JW. Three habits of highly effective signaling pathways: principles of transcriptional control by developmental cell signaling. Genes Dev. 2002;16:1167–1181. [PubMed] 82. Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao Y, et al. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat Methods. 2007;4:651–657. [PubMed] 83. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003;31:e15. [PubMed] 84. Saeed AI, Sharov V, White J, Li J, Liang W, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 2003;34:374–378. [PubMed] 85. Johnson WE, Li W, Meyer CA, Gottardo R, Carroll JS, et al. Model-based analysis of tiling-arrays for ChIP-chip. Proc Natl Acad Sci U S A. 2006;103:12457–12462. [PubMed] 86. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:RESEARCH0034. [PubMed] 87. Ovodenko B, Rostagno A, Neubert TA, Shetty V, Thomas S, et al. Proteomic analysis of exfoliation deposits. Invest Ophthalmol Vis Sci. 2007;48:1447–1457. [PubMed] 88. Pera EM, Wessely O, Li SY, De Robertis EM. Neural and head induction by insulin-like growth factor signals. Dev Cell. 2001;1:655–665. [PubMed] 89. Grinchuk O, Kozmik Z, Wu X, Tomarev S. The Optimedin gene is a downstream target of Pax6. J Biol Chem. 2005;280:35228–35237. [PubMed] 90. Gilmour DT, Lyon GJ, Carlton MB, Sanes JR, Cunningham JM, et al. Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. Embo J. 1998;17:1860–1870. [PubMed] 91. Higashijima S, Nose A, Eguchi G, Hotta Y, Okamoto H. Mindin/F-spondin family: novel ECM proteins expressed in the zebrafish embryonic axis. Dev Biol. 1997;192:211–227. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||
Trends Genet. 2002 Jan; 18(1):41-7.
[Trends Genet. 2002]Annu Rev Cell Dev Biol. 2007; 23():645-73.
[Annu Rev Cell Dev Biol. 2007]Nature. 1991 Dec 19-26; 354(6354):522-5.
[Nature. 1991]Nature. 1997 May 22; 387(6631):406-9.
[Nature. 1997]Prog Retin Eye Res. 2007 Nov; 26(6):555-97.
[Prog Retin Eye Res. 2007]Cell. 2001 Apr 6; 105(1):43-55.
[Cell. 2001]Bioessays. 2004 Apr; 26(4):374-86.
[Bioessays. 2004]Development. 2000 Jun; 127(12):2563-72.
[Development. 2000]Trends Neurosci. 2002 Jan; 25(1):32-8.
[Trends Neurosci. 2002]Mol Cell Neurosci. 2007 Jan; 34(1):99-119.
[Mol Cell Neurosci. 2007]PLoS Genet. 2007 Oct; 3(10):1867-83.
[PLoS Genet. 2007]Proc Natl Acad Sci U S A. 2003 Apr 1; 100(7):4024-9.
[Proc Natl Acad Sci U S A. 2003]Genome Res. 2006 Apr; 16(4):466-76.
[Genome Res. 2006]Mol Cell Neurosci. 2007 Jan; 34(1):99-119.
[Mol Cell Neurosci. 2007]Proc Natl Acad Sci U S A. 2001 Aug 14; 98(17):9688-93.
[Proc Natl Acad Sci U S A. 2001]EMBO J. 2006 May 17; 25(10):2107-18.
[EMBO J. 2006]Proc Natl Acad Sci U S A. 2001 Aug 14; 98(17):9688-93.
[Proc Natl Acad Sci U S A. 2001]Mech Dev. 2002 Oct; 118(1-2):3-17.
[Mech Dev. 2002]EMBO J. 2006 May 17; 25(10):2107-18.
[EMBO J. 2006]Mol Cell Biol. 1998 Sep; 18(9):5579-86.
[Mol Cell Biol. 1998]J Mol Biol. 2004 Nov 19; 344(2):351-68.
[J Mol Biol. 2004]Nucleic Acids Res. 2007 Jul; 35(Web Server issue):W91-6.
[Nucleic Acids Res. 2007]Dev Biol. 2004 Oct 15; 274(2):295-307.
[Dev Biol. 2004]Development. 1995 Nov; 121(11):3615-26.
[Development. 1995]Development. 2004 Dec; 131(24):6119-29.
[Development. 2004]J Cell Sci. 2002 Nov 1; 115(Pt 21):4053-9.
[J Cell Sci. 2002]Invest Ophthalmol Vis Sci. 2007 Dec; 48(12):5408-19.
[Invest Ophthalmol Vis Sci. 2007]Nucleic Acids Res. 2007 Jul; 35(Web Server issue):W91-6.
[Nucleic Acids Res. 2007]Genome Biol. 2002 Jun 18; 3(7):RESEARCH0034.
[Genome Biol. 2002]Nat Rev Genet. 2006 Jan; 7(1):55-65.
[Nat Rev Genet. 2006]Prog Retin Eye Res. 2007 Nov; 26(6):555-97.
[Prog Retin Eye Res. 2007]Bioessays. 2002 Nov; 24(11):1041-51.
[Bioessays. 2002]Mol Cell Neurosci. 2007 Jan; 34(1):99-119.
[Mol Cell Neurosci. 2007]Cell. 1994 Dec 30; 79(7):1209-20.
[Cell. 1994]Mol Cell Neurosci. 2007 Jan; 34(1):99-119.
[Mol Cell Neurosci. 2007]J Biol Chem. 1994 Mar 18; 269(11):8355-61.
[J Biol Chem. 1994]Development. 1996 Sep; 122(9):2639-50.
[Development. 1996]J Cell Sci. 2000 Sep; 113 ( Pt 18)():3173-85.
[J Cell Sci. 2000]J Mol Biol. 2005 Aug 19; 351(3):453-69.
[J Mol Biol. 2005]J Biol Chem. 1997 May 30; 272(22):14175-82.
[J Biol Chem. 1997]J Embryol Exp Morphol. 1986 Sep; 97():95-110.
[J Embryol Exp Morphol. 1986]Development. 1995 May; 121(5):1433-42.
[Development. 1995]Development. 1991 Dec; 113(4):1435-49.
[Development. 1991]Mol Cell Neurosci. 2007 Jan; 34(1):99-119.
[Mol Cell Neurosci. 2007]Cell Tissue Res. 2003 Jul; 313(1):1-10.
[Cell Tissue Res. 2003]Proc Natl Acad Sci U S A. 2001 Aug 14; 98(17):9688-93.
[Proc Natl Acad Sci U S A. 2001]Mech Dev. 2002 Oct; 118(1-2):3-17.
[Mech Dev. 2002]Dev Biol. 2001 Dec 15; 240(2):419-32.
[Dev Biol. 2001]J Biol. 2005; 4(3):11.
[J Biol. 2005]Mol Cell Neurosci. 2007 Jan; 34(1):99-119.
[Mol Cell Neurosci. 2007]Genes Dev. 1999 Jul 1; 13(13):1647-52.
[Genes Dev. 1999]J Comp Neurol. 2005 Jul 4; 487(3):255-69.
[J Comp Neurol. 2005]Mol Cell Neurosci. 2007 Sep; 36(1):1-12.
[Mol Cell Neurosci. 2007]Development. 2001 Oct; 128(20):3987-94.
[Development. 2001]J Proteome Res. 2008 Jan; 7(1):311-8.
[J Proteome Res. 2008]Proc Natl Acad Sci U S A. 2006 May 30; 103(22):8419-24.
[Proc Natl Acad Sci U S A. 2006]Gastroenterology. 2006 Apr; 130(4):1207-20.
[Gastroenterology. 2006]Curr Biol. 2000 Mar 23; 10(6):301-10.
[Curr Biol. 2000]J Bone Miner Res. 2006 Jul; 21(7):1034-44.
[J Bone Miner Res. 2006]Bone. 2006 Oct; 39(4):724-38.
[Bone. 2006]Prog Retin Eye Res. 2007 Nov; 26(6):555-97.
[Prog Retin Eye Res. 2007]Exp Eye Res. 2008 Jun; 86(6):895-907.
[Exp Eye Res. 2008]Development. 1997 Jan; 124(1):219-31.
[Development. 1997]Gene Expr Patterns. 2005 Dec; 6(1):110-8.
[Gene Expr Patterns. 2005]Oncogene. 1995 Jan 19; 10(2):329-40.
[Oncogene. 1995]Dev Biol. 1999 Mar 1; 207(1):176-88.
[Dev Biol. 1999]Proc Natl Acad Sci U S A. 2004 Dec 7; 101(49):17144-9.
[Proc Natl Acad Sci U S A. 2004]Dev Biol. 2000 May 1; 221(1):10-22.
[Dev Biol. 2000]Mech Dev. 2000 Nov; 98(1-2):37-50.
[Mech Dev. 2000]Prog Retin Eye Res. 2007 Nov; 26(6):555-97.
[Prog Retin Eye Res. 2007]Dev Biol. 2004 Oct 15; 274(2):295-307.
[Dev Biol. 2004]Development. 2003 May; 130(9):1759-70.
[Development. 2003]BMC Cell Biol. 2004 Dec 21; 5(1):48.
[BMC Cell Biol. 2004]Dev Biol. 1999 Mar 1; 207(1):176-88.
[Dev Biol. 1999]Nature. 2003 Aug 28; 424(6952):1071-4.
[Nature. 2003]Invest Ophthalmol Vis Sci. 2007 Dec; 48(12):5638-46.
[Invest Ophthalmol Vis Sci. 2007]Dev Dyn. 2008 Mar; 237(3):602-17.
[Dev Dyn. 2008]Prog Retin Eye Res. 2007 Nov; 26(6):555-97.
[Prog Retin Eye Res. 2007]J Biol Chem. 2002 Mar 29; 277(13):11539-48.
[J Biol Chem. 2002]Nat Rev Genet. 2006 Jan; 7(1):55-65.
[Nat Rev Genet. 2006]PLoS Genet. 2007 Oct; 3(10):1867-83.
[PLoS Genet. 2007]Mol Cell Neurosci. 2007 Jan; 34(1):99-119.
[Mol Cell Neurosci. 2007]PLoS Genet. 2007 Oct; 3(10):1867-83.
[PLoS Genet. 2007]Genes Dev. 2002 May 15; 16(10):1167-81.
[Genes Dev. 2002]Nat Methods. 2007 Aug; 4(8):651-7.
[Nat Methods. 2007]Nature. 1997 May 22; 387(6631):406-9.
[Nature. 1997]Nucleic Acids Res. 2003 Feb 15; 31(4):e15.
[Nucleic Acids Res. 2003]Biotechniques. 2003 Feb; 34(2):374-8.
[Biotechniques. 2003]Nucleic Acids Res. 2007 Jul; 35(Web Server issue):W91-6.
[Nucleic Acids Res. 2007]Proc Natl Acad Sci U S A. 2006 Aug 15; 103(33):12457-62.
[Proc Natl Acad Sci U S A. 2006]Genome Biol. 2002 Jun 18; 3(7):RESEARCH0034.
[Genome Biol. 2002]EMBO J. 2006 May 17; 25(10):2107-18.
[EMBO J. 2006]J Biol Chem. 1994 Mar 18; 269(11):8355-61.
[J Biol Chem. 1994]Development. 1996 Sep; 122(9):2639-50.
[Development. 1996]J Cell Sci. 2000 Sep; 113 ( Pt 18)():3173-85.
[J Cell Sci. 2000]